Screening Study for Participants With Malignant Tumors
Completed · Phase 2
Conditions studied: Solid Tumors
In brief
The study objective is to determine the biomarker status of a participant's tumor tissue and use that status to determine eligibility for a linked Roche clinical trial.
Key facts
- Study ID
- NCT05419375
- Run by
- Hoffmann-La Roche
- People needed
- 470
- Starts
- 2022-07-22
- Expected to finish
- 2025-09-03
- Last updated by the study team
- 2026-02-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Texas Oncology, P.A. — Austin, Texas, United States
- Texas Oncology- Northeast Texas — Tyler, Texas, United States
- Oncology & Hematology Associates of Southwest Virginia, Inc — Blacksburg, Virginia, United States
- Northwest Cancer Specialists — Vancouver, Washington, United States
- One Clinical Research — Nedlands, Western Australia, Australia
- COT - Centro Oncologico do Triangulo — Uberlândia, Minas Gerais, Brazil
- Santa Casa de Misericordia de Porto Alegre — Porto Alegre, Rio Grande do Sul, Brazil
- Hospital de Clínicas de Porto Alegre X — Porto Alegre, Rio Grande do Sul, Brazil
- Clínica de Oncologia Reichow — Blumenau, Santa Catarina, Brazil
- Instituto do Cancer do Estado de Sao Paulo - ICESP — São Paulo, São Paulo, Brazil
- Oncoclinicas Rio de Janeiro S.A. — Rio de Janeiro, Brazil
- Sunnybrook Health Sciences Centre — Toronto, Ontario, Canada
- Centro de Estudios Clínicos SAGA — Santiago, Chile
- RedSalud Vitacura — Santiago, Chile
- Clinica De La Costa — Barranquilla, Colombia
- Hospital Universitario San Ignacio — Bogotá, Colombia
- Instituto Cancerología Medellin — Medellín, Colombia
- Clinica CIMCA — San José, Costa Rica
- ICIMED Instituto de Investigación en Ciencias Médicas — San José, Costa Rica
- Centre Leon Berard — Lyon, France
- Hia Sainte Anne — Toulon, France
- Klinikum rechts der Isar der TU Muenchen — München, Germany
- Asklepios Klinik Gauting — München-Gauting, Germany
- Queen Mary Hospital — Hong Kong, Hong Kong
- Thompson Cancer Survival Center — Knoxville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.